|
|
|
Volumn 34, Issue 32, 2013, Pages 2496-2497
|
|
First drug to improve heart failure mortality in over a decade: coenzyme Q10 decreases all-cause mortality by half in randomized double blind trial.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARDIOTONIC AGENT;
DRUG DERIVATIVE;
UBIDECARENONE;
UBIQUINONE;
ARTICLE;
DOUBLE BLIND PROCEDURE;
HEART FAILURE;
HUMAN;
MORTALITY;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
TREATMENT OUTCOME;
ANALOGS AND DERIVATIVES;
CARDIOTONIC AGENTS;
DOUBLE-BLIND METHOD;
HEART FAILURE;
HUMANS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
TREATMENT OUTCOME;
UBIQUINONE;
|
|
EID: 84896143164
PISSN: None
EISSN: 15229645
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|